PYC — PYC Therapeutics Balance Sheet
0.000.00%
- AU$699.91m
- AU$652.13m
- AU$22.86m
- 26
- 14
- 26
- 10
Annual balance sheet for PYC Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25.4 | 51.5 | 29.1 | 15.6 | 66.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.083 | 0.186 | 10.1 | 16.3 | 18 |
Prepaid Expenses | |||||
Total Current Assets | 25.6 | 51.8 | 39.2 | 31.9 | 85.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.14 | 1.49 | 1.63 | 1.04 | 1.57 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 31.5 | 57.9 | 45.4 | 37.2 | 91.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.706 | 3.3 | 4.39 | 8.41 | 9.11 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.59 | 4.9 | 6 | 9.42 | 10.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 28 | 53 | 39.4 | 27.7 | 80.5 |
Total Liabilities & Shareholders' Equity | 31.5 | 57.9 | 45.4 | 37.2 | 91.2 |
Total Common Shares Outstanding |